Author:
Tourbah Ayman,Papeix Caroline,Tourniaire Patricia,Rerat Karin,Meite Mohamed,Durand Barbara,Lamy Fabienne,Chouette Isabelle,Mekies Claude
Subject
Neurology (clinical),Neurology,General Medicine
Reference19 articles.
1. Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study;Bergvall;PloS one,2014
2. Long-term effectiveness, safety and tolerability with fingolimod treatment in patients with multiple sclerosis in real-world treatment settings in France: final results of the VIRGILE study;Castelnovo;Multiple sclerosis (Houndmills, Basingstoke, England),2019
3. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;The New England journal of medicine,2010
4. Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS;Cohen;Journal of neurology,2013
5. Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis;Druart;Patient related outcome measures,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献